Oliver Ekman-Larsson has a new number ahead of his first season in the Maple Leafs organization. The veteran defenseman is ...

Oliver Ekman-Larsson is hoping his Swedish connection will help Toronto make a deep post-season run in the 2024-25 campaign.

After another underwhelming year on the defensive front in 2023-24, Toronto brought in acclaimed veteran blueliners Oliver ...

The Toronto Maple Leafs made some impressive additions this offseason that have improved their defensive depth, as well as ...

Craig Berube wil be behind the Maple Leafs’ bench for the first time while Auston Matthews sports the captain’s “C” as ...

In addition to the 6-foot-2, 191-pound Oliver Ekman-Larsson, who signed a four-year contract, the Maple Leafs added ...

What Chris Tanev and Oliver Ekman-Larsson Will Bring to the Maple Leafs' Blueline After another underwhelming year on the defensive front in 2023-24, Toronto brought in acclaimed veteran ...

Trade Pitch has the Toronto Maple Leafs Acquiring star defenseman Jamie Oleksiak from the Seattle Kraken in a blockbuster.

A proposed trade between the Toronto Maple Leafs and the Seattle Kraken, crafted by a user on PuckPedia’s PuckGM tool, raises ...

Toronto Maple Leafs defenseman Oliver Ekman-Larsson recently caught up with Arizona Coyotes insider Craig Morgan, a man who ...

预防性抗凝治疗对于ALK阳性非小细胞肺癌（NSCLC）患者来说是一个有潜力的干预方法，尤其是在识别和管理静脉血栓栓塞（VTE）风险方面。在本届WCLC大会上，梅斯医学邀请到了来自瑞典卡罗林斯卡大学医院的高级顾问、肿瘤学教授，以及卡罗林斯卡研究所肺癌研究负责人Simon Ekman教授深入解读当下ALK阳性NSCLC患者的VTE风险评估与预防策略。

Carter Yakemchuk scored a sensational overtime winner off an end-to-end rush to lead the Ottawa Senators past the Toronto ...